Dr. Gloria Grice | Pharmacy | Best Researcher Award

Dr. Gloria Grice | Pharmacy | Best Researcher Award

Dr. Gloria Grice, University of Health Sciences and Pharmacy in St. Louis, United States

Gloria R. Grice, Pharm.D., is an accomplished academic leader and healthcare professional. She currently serves as the Associate Dean for Academic Affairs at the St. Louis College of Pharmacy, University of Health Sciences and Pharmacy in Saint Louis. With over two decades of experience in pharmacy education, Dr. Grice holds additional roles as a Professor (Non-Tenure Track) in the Department of Pharmacy Practice and a Courtesy Assistant Professor at Goldfarb School of Nursing. She earned her Doctor of Pharmacy degree from the University of Maryland, where she also completed pre-pharmacy coursework. Dr. Grice’s expertise spans pharmacotherapy, pharmacy practice, and interprofessional healthcare education. She has been recognized for her contributions to student-centered learning and ability-based education. Throughout her career, Dr. Grice has led innovative teaching and clinical practice initiatives, preparing future healthcare professionals to excel in diverse clinical settings.

Professional Profile

google scholar

Evaluation for Research for Best Researcher Award: Gloria R. Grice

Summary of Suitability
Gloria R. Grice stands out as a highly accomplished academic and healthcare professional with extensive experience in both clinical practice and academic leadership. Her tenure as Associate Dean for Academic Affairs, coupled with her long-standing role as a Professor in Pharmacy Practice, highlights her capacity for leadership, mentorship, and innovation in pharmacy education. Her rich educational background, including a Doctor of Pharmacy degree from the University of Maryland, and her specialty residency in Family Medicine, establish her as an expert in her field.

  🎓 Education 

Gloria R. Grice completed her Doctor of Pharmacy (Pharm.D.) from the University of Maryland, Baltimore, in May 2002. Prior to her Pharm.D., she pursued Pre-Pharmacy studies at the University of Maryland, College Park, from 1996 to 1998. Her academic journey was marked by an emphasis on both foundational science and clinical pharmacy practice. Dr. Grice’s education has laid the groundwork for her extensive involvement in pharmacy practice and academic leadership. Her passion for advancing pharmacy education is reflected in her current role as Associate Dean for Academic Affairs and as a Professor (Non-Tenure Track) in the Department of Pharmacy Practice. Dr. Grice continues to contribute to educational advancements by developing innovative curricula that integrate pharmacotherapy, interprofessional education, and patient-centered care approaches.

 💼 Experience

Dr. Gloria R. Grice has over two decades of experience in pharmacy practice and academia. Since July 2021, she has been the Associate Dean for Academic Affairs at the St. Louis College of Pharmacy, University of Health Sciences and Pharmacy in Saint Louis. She has also held the role of Professor (Non-Tenure Track) in the Department of Pharmacy Practice since 2015. Dr. Grice’s teaching career includes serving as a course coordinator, lecturer, and preceptor for numerous pharmacy and interprofessional education courses. Her earlier roles include Clinical Instructor and Clerkship Preceptor, where she provided experiential education in primary care and geriatrics. Dr. Grice’s residency at St. John’s Mercy Family Medicine expanded her clinical practice in various specialties, including internal medicine and geriatrics. Her clinical and educational expertise continues to shape the next generation of pharmacists and healthcare professionals.

  🏅Awards and Honors 

Dr. Gloria R. Grice has received several recognitions for her contributions to pharmacy education and clinical practice. She holds certifications in Advanced Cardiac Life Support (ACLS) and Immunization from the American Pharmacists Association, demonstrating her clinical proficiency. Additionally, she has been a Board Certified Pharmacotherapy Specialist since 2003, further renewed in 2010 and 2017, underscoring her expertise in pharmacotherapy. Dr. Grice is also licensed to practice pharmacy in both Missouri and Maryland. Throughout her career, she has been honored for her commitment to student-centered, ability-based education, particularly in the areas of primary care and interprofessional healthcare education. Her role in shaping experiential learning and preceptorship has earned her significant respect among peers and students alike. Dr. Grice’s leadership in academic administration further exemplifies her dedication to advancing the field of pharmacy education.

  🌍 Research Focus 

Dr. Gloria R. Grice’s research focuses on interprofessional education, pharmacotherapy, and innovative approaches to healthcare education. She is particularly interested in how collaborative, patient-centered care can be enhanced through better integration of pharmacists into interprofessional healthcare teams. Her work explores the role of pharmacy in managing chronic conditions such as diabetes, hypertension, and heart failure, as well as the optimization of pharmacogenomics in primary care settings. Dr. Grice has contributed to research on educational strategies, including ability-based learning and assessment-driven methodologies. Her goal is to advance the quality of pharmacy education, preparing healthcare professionals to deliver comprehensive, team-based care. Dr. Grice’s research also highlights the importance of experiential learning and preceptorship in cultivating future leaders in pharmacy practice.

  📖 Publications Top Notes

Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin
  • Citations: 998
Integration of genetic, clinical, and INR data to refine warfarin dosing
  • Citations: 267
Genetic-based dosing in orthopedic patients beginning warfarin therapy
  • Citations: 225
A polymorphism in the VKORC1 regulator calumenin predicts higher warfarin dose
  • Citations: 126
Laboratory and clinical outcomes of pharmacogenetic vs. clinical protocols for warfarin initiation in orthopedic patients
  • Citations: 100

 

MANSOUREH BARADARAN | Medicine and Dentistry | Best Researcher Award

Dr MANSOUREH BARADARAN | Medicine and Dentistry | Best Researcher Award

Dr.mansoureh baradaran, North Khorasan University of Medical Sciences, Iran 

Dr. Mansoureh Baradaran is a board-certified radiologist in Iran, with extensive experience in diagnostic imaging and research collaborations. She holds expertise in conducting systematic reviews and meta-analyses in the radiology field, focusing on neurological, oncological, and radiomics studies. Dr. Baradaran has been involved in collaborative projects with prestigious institutions like UCLA, UCSD, and UAB, working on cutting-edge research in artificial intelligence applications in healthcare. Her clinical skills include professional reporting on a variety of imaging modalities, including whole-body MRI and CT scans, mammography, and ultrasound. Throughout her career, she has authored numerous research papers and book chapters in the field of radiology. Dr. Baradaran is passionate about integrating modern technologies like AI into medical imaging and improving diagnostic accuracy. She is an active member of international radiological societies, contributing to advancements in the global radiology community.

Professional profile

google scholar

Evaluation of Mansoureh Baradaran, M.D. for the Research for Best Researcher Award

Mansoureh Baradaran, M.D., presents a remarkable profile in radiology research, with a strong international research background. She has participated in numerous collaborative research projects across prestigious institutions such as UCSD, UCLA, and UAB. Her focus on using artificial intelligence in radiology for predictive analysis, as well as her involvement in high-impact studies on topics like Alzheimer’s disease, COVID-19, and cancer, highlights her expertise in radiomics and systematic reviews. Furthermore, Dr. Baradaran has published extensively, with notable research papers in reputable journals, reflecting her capacity for high-quality scholarly output. Her presentations at international conferences like the Society of Interventional Radiology (SIR) 2023 also emphasize her active engagement with the global research community.

Education :

Dr. Mansoureh Baradaran completed her radiology residency at Mashhad University of Medical Sciences, Razavi Khorasan, Iran, between 2016 and 2020. She graduated with a GPA of 17.80/20 and conducted her thesis on the pathologic results of stereotactic core needle biopsy in patients suspicious for malignancy through microcalcifications in mammography. Prior to this, she earned her Doctor of Medicine (M.D.) degree from Birjand University of Medical Sciences, South Khorasan, Iran, in 2016, with a GPA of 18.50/20. Her medical thesis investigated serum lipid levels in patients with thalassemia major compared to the control group. Dr. Baradaran’s education has been rooted in rigorous clinical and research training, allowing her to develop extensive knowledge in radiology, diagnostic imaging, and related research fields. Her educational background reflects a strong commitment to both clinical excellence and research contributions in medical science.

Experience :

Dr. Mansoureh Baradaran currently practices as a radiologist at Dr. Mohajerzadeh Private Radiology Clinic in Bojnurd, Iran, and the Avan Advanced Private Medical Center in Mashhad, Iran. She specializes in performing and interpreting imaging modalities, including ultrasounds, MRI, CT scans, and mammography. Between 2020 and 2024, she worked at North Khorasan University of Medical Science’s hospitals, where she gained extensive experience in diagnostic imaging and reporting across various radiological fields. Dr. Baradaran has also been actively involved in international research collaborations, contributing to studies on artificial intelligence, radiomics, and neurological imaging. These collaborations include working with top institutions like UCLA, UCSD, and UAB on projects such as AI applications in hepatocellular carcinoma recurrence and diagnostic performance of MRI radiomics for Alzheimer’s disease. Her hands-on clinical work is complemented by her commitment to advancing radiological research and diagnostics.

Awards and Honors :

Dr. Mansoureh Baradaran has earned several prestigious accolades throughout her medical and academic career. She secured a double-digit rank in Iran’s highly competitive entrance exam for medical specialties in May 2016, a testament to her academic prowess. Additionally, she achieved national recognition with a high rank in Iran’s basic medical science exam in September 2011. Her exceptional academic performance during her radiology residency, with a GPA of 17.80/20, further highlights her commitment to excellence in her field. Dr. Baradaran’s achievements are not limited to exams; she has co-authored numerous research papers and book chapters, contributing significantly to medical science. Her work in artificial intelligence applications in radiology and diagnostic imaging has been recognized at international conferences such as the Society of Interventional Radiology (SIR) 2023. These awards and honors reflect her dedication to both clinical practice and innovative medical research.

Research Focus :

Dr. Mansoureh Baradaran’s research is focused on diagnostic radiology, radiomics, and the integration of artificial intelligence (AI) in medical imaging. She has contributed to numerous systematic reviews and meta-analyses in areas such as Alzheimer’s disease, lung cancer, and neurological complications related to COVID-19. A significant portion of her research involves the use of radiomics for predictive modeling in diseases like non-small cell lung cancer and hepatocellular carcinoma. Her work aims to enhance diagnostic accuracy through the application of advanced imaging techniques and AI-driven technologies. Dr. Baradaran is particularly interested in how AI can improve the early detection of disease recurrence and optimize treatment outcomes. Additionally, her research on olfactory dysfunction related to COVID-19 has provided valuable insights into the long-term effects of the virus on neuroimaging. Her contributions to radiology extend beyond clinical applications, delving into the future of AI in healthcare diagnostics.

Publications Top Notes:

  1. Diagnostic performance of MRI radiomics for classification of Alzheimer’s disease, mild cognitive impairment, and normal subjects 🧠📊
  2. Prognostic value of CT scan-based radiomics in intracerebral hemorrhage patients 🩸📈
  3. Brain MRI findings in neurologically symptomatic COVID-19 patients 🦠🧠
  4. Legg-Calve-Perthes Disease: A comprehensive review of diagnosis, management, and current treatment options 🦴👩‍⚕️
  5. Diagnostic performance of radiomics in prediction of Ki-67 index status in non-small cell lung cancer 🫁📉
  6. Olfactory dysfunction in the COVID-19 era: An umbrella review focused on neuroimaging 👃🦠
  7. Pathologic results of stereotactic core needle biopsy in patients suspicious to microcalcification on mammography 🔬🩺
  8. Cystic teratoma of the oral cavity 👶👄
  9. Spontaneous rupture of accessory spleen 16 years after splenectomy 🩸🧬
  10. Spontaneous rupture of splenic artery aneurysm in a pregnant woman 🩸🤰

 

Leandro Conte | Environmental Science | Best Researcher Award

Prof Dr Leandro Conte | Environmental Science | Best Researcher Award

Prof.Dr.leandro conte, Instituto de Desarrollo Tecnológico para la Industria Química (INTEC). CONICET, CCT-Santa Fe, Argentina, Argentina

Dr. Leandro Oscar Conte is a prominent environmental engineer and researcher, currently serving as an Associate Researcher at the Instituto de Desarrollo Tecnológico para la Industria Química (INTEC), CONICET-CCT Santa Fe, Argentina. He also holds an Associate Professor position at the Facultad de Ingeniería y Ciencias Hídricas (FICH), UNL. Dr. Conte’s expertise lies in Advanced Oxidation Processes for the degradation of Persistent Organic Pollutants. Since joining INTEC in 2016 as an Assistant Researcher, he has made significant contributions to water and soil remediation technologies. His research has been widely recognized, with 25 articles published and two book chapters. He has secured several high-profile research grants, including a Marie Curie Fellowship at Universidad Complutense de Madrid (UCM), Spain. Dr. Conte has established himself as a leader in his field, promoting sustainable environmental practices.

Professional Profile

scopus

orcid

 

Education:

Dr. Leandro Conte earned his degree in Environmental Engineering from the Universidad Nacional del Litoral (UNL) in 2008, where he also completed his Ph.D. in Environmental Engineering in 2015. His doctoral research focused on the development of novel advanced oxidation technologies for environmental remediation. Dr. Conte’s academic journey was marked by significant milestones, including scholarships and fellowships that allowed him to conduct cutting-edge research both nationally and internationally. He further honed his expertise through postdoctoral work at renowned institutions, including a Marie Curie Fellowship at Universidad Complutense de Madrid (UCM) in Spain. His commitment to academic excellence has earned him numerous accolades, and he has continued to advance his knowledge in the environmental engineering field through ongoing research collaborations. Dr. Conte’s educational background has formed a solid foundation for his career as a researcher and academic leader.

Experience :

Dr. Leandro Conte began his career as an Assistant Researcher at INTEC, Argentina, in 2016, where he quickly advanced to the position of Associate Researcher in 2019. His academic career also flourished with his appointment as an Associate Professor at UNL in 2018. Dr. Conte’s experience extends internationally, having served as a Guest Professor at UCM from 2021-2022, where he expanded his research on advanced oxidation processes. His involvement in over a dozen research projects, many as project director, underscores his leadership and expertise in the field. Dr. Conte has also been an evaluator for research programs and contributed as a reviewer for international journals. His broad experience and interdisciplinary collaborations have been instrumental in addressing critical environmental issues related to water and soil contamination, making him a key figure in his field.

Awards and Honors:

Dr. Leandro Conte’s distinguished career has been marked by numerous awards and recognitions. He received the prestigious Marie Curie Fellowship (GA-844209) for his research at UCM in Spain, focusing on the photo-Fenton degradation of persistent organic pollutants. His contributions to environmental engineering were further acknowledged when he achieved ANECA certification and R3 accreditation from the Spanish State Agency of Research (AEI). Additionally, Dr. Conte has been a recipient of multiple research grants, such as the highly competitive PICT funding from Argentina’s ANPCyT. His research leadership has earned him recognition within both national and international scientific communities. These accolades reflect his dedication to advancing environmental remediation technologies and his commitment to sustainable environmental practices.

Research Focus :

Dr. Leandro Conte’s research primarily revolves around Advanced Oxidation Processes (AOPs) for the degradation of persistent pollutants in water and soil. His work focuses on developing and optimizing solar photo-Fenton, ozonation, and persulfate-based reactions to address contaminants of emerging concern. Dr. Conte’s research seeks to bridge the gap between laboratory-scale experimentation and large-scale environmental applications, using pilot plant reactors to test the efficacy of AOPs in real-world conditions. His studies have led to novel insights into the degradation mechanisms of organic pollutants and have explored the synergy between various AOPs to improve treatment efficiency. His collaborations with international institutions have helped propel his research to new heights, with a particular emphasis on sustainable environmental technologies. Dr. Conte’s research is at the forefront of efforts to mitigate the impact of industrial and pharmaceutical pollutants on ecosystems.

Publications Top Notes:

  1. 🌍 “Application of Solar Photo-Fenton for Degrading Emerging Pollutants in Water”
  2. 💧 “Advanced Oxidation Techniques in Wastewater Treatment: A Comprehensive Review”
  3. 🧪 “Degradation of Persistent Organic Pollutants using Ozone and UV”
  4. ☀️ “Pilot-Scale Solar Reactors for Contaminant Removal in Real Waters”
  5. 🔬 “Comparative Study of Persulfate and Fenton Processes for Pollutant Degradation”
  6. 🌱 “Sustainable Water Treatment: Challenges in Emerging Pollutants”
  7. 🌡️ “Optimizing Solar Fenton-Like Reactions for Real Contaminated Waters”
  8. ⚙️ “Innovative Reactants for Advanced Oxidation Processes in Soil Remediation”
  9. 🏭 “Industrial Applications of Advanced Oxidation Technologies”
  10. 🧫 “Modeling the Kinetics of Ozone-Based Contaminant Degradation”

 

 

Mohammadreza Alizadeh | Medicine and Dentistry | Best Researcher Award Iran

Dr Mohammadreza Alizadeh | Medicine and Dentistry | Best Researcher Award

Dr.Mohammadreza Alizadeh, Iran University of Medical Sciences, Iran

Dr. Mohammadreza (Danial) Alizadeh is a highly skilled medical doctor with expertise in general and aesthetic practice. He graduated from Shahid Beheshti University of Medical Sciences, where he earned his Doctor of Medicine degree in 2020. With a passion for combining medicine and technology, Dr. Alizadeh’s diverse experiences span neurology, radiology, and health management. Currently, he serves as the Supervisor of Occupational Safety and Health at Saman Dej Alborz Co, while practicing as a General Practitioner in Mazandaran, Iran. His contributions to medical research, especially in neuroimaging, neurology, and brain injuries, reflect his commitment to advancing medical knowledge. Dr. Alizadeh is also fluent in Persian, English, and proficient in several other languages, which enhances his ability to collaborate in global settings. A passionate researcher, he has authored numerous publications in high-impact journals, particularly in neuroimaging and trauma.

Professional Profile

  • google scholor

    Experience:

    Dr. Mohammadreza (Danial) Alizadeh has gained a wealth of experience across diverse medical settings. Since May 2023, he has been working as the Supervisor of Occupational Safety and Health at Saman Dej Alborz Co., Tehran, where he oversees safety protocols in a corporate environment. In parallel, he practices as a General and Aesthetic Practitioner in Amol, Mazandaran, focusing on skincare, aesthetic treatments, and general medicine. From March 2019 to February 2021, Dr. Alizadeh held the same role at Derma Hall Clinic, Tehran, performing various cosmetic procedures and consultations. His formative experience includes a two-year internship at Shahid Beheshti University of Medical Sciences, where he rotated through various medical departments, solidifying his expertise in clinical decision-making, patient care, and research. Throughout his career, he has blended patient care with research, focusing on neuroimaging and radiology, with multiple publications in renowned journals.

    Awards and Honors:

    Dr. Mohammadreza (Danial) Alizadeh has been recognized for his academic and professional excellence throughout his career. His notable achievements include an honor for his contribution to neuroimaging research, particularly in traumatic brain injuries, which has gained international recognition. He has received several awards for his scientific publications in peer-reviewed journals, reflecting his deep involvement in advancing medical science. Dr. Alizadeh was also awarded a distinction for his work in healthcare management during his MBA at Shahid Beheshti University of Medical Sciences, highlighting his leadership capabilities in both clinical and managerial roles. His participation in international conferences and workshops has earned him accolades from the medical community, particularly for his innovative research on neuroimaging techniques in radiology. Moreover, his expertise in aesthetic medicine has brought him local recognition, particularly for his minimally invasive cosmetic procedures.

    Research Focus:

    Dr. Mohammadreza (Danial) Alizadeh’s research primarily focuses on neuroimaging and its application in understanding neurological conditions and brain injuries. He is particularly interested in the diagnostic use of MRI and radiomics in the detection and progression of conditions such as glioblastoma and traumatic brain injury. His research also extends to exploring neuroinflammatory responses and imaging abnormalities associated with neurodegenerative diseases. Dr. Alizadeh is actively involved in studying the impact of aducanumab immunotherapy on amyloid-related imaging abnormalities, a groundbreaking area in Alzheimer’s treatment. His work on the role of psychiatric disorders and neuroimaging has opened new avenues for diagnosing and treating mental health conditions using cutting-edge imaging technologies. Additionally, his research on biomarkers in neurotrauma and the use of artificial intelligence in radiological interpretations reflects his forward-thinking approach to medical research.

    Publications Top Notes:

    1. 🧠 “Imaging spectrum of amyloid-related imaging abnormalities associated with aducanumab immunotherapy”
    2. 🧪 “Clinical Decision Rules in Predicting CT Findings in Mild Traumatic Brain Injury”
    3. 🧬 “Radiomics: Differentiating Progression, Recurrence, and Radionecrosis in Gliomas”
    4. 🦠 “ALK-Positive Histiocytosis: A Deceptive Mimic of Meningioma”
    5. 🧠 “Radiomics in Psychiatric Disorders: An Emerging Diagnostic Tool”
    6. 🦠 “MRI Findings in COVID-19 Associated Encephalitis”
    7. 🧠 “Subcortical Signal Alteration of Corticospinal Tracts in ARIA”
    8. 🧠 “Serum Glial Fibrillary Acidic Protein for Intracranial Lesion Detection”
    9. 🩺 “Migraine and Subclinical Atherosclerosis: A Correlation Study”
    10. 🦠 “Effect of Underlying Diseases on COVID-19 Mortality Rate”
    11. 👶 “Choledochal Cyst in Pregnancy: A Case Report”
    12. 🧠 “Double Cystic Duct Case Report”
    13. 🧪 “Effect of Workshop vs. Lecture on Nursing and Midwifery Students”

 

David Monroy | Ocular Cancer | Best Researcher Award

David Monroy | Ocular Cancer | Best Researcher Award

  David Monroy, University of Miami, United States

David Monroy is a dedicated researcher with a strong background in neurocritical care and ophthalmology research. A graduate of Florida International University with a Bachelor of Science in Biological Sciences, David has developed significant expertise through his involvement in cutting-edge research projects. He has contributed to impactful studies at the University of Miami’s Neurology and Bascom Palmer Eye Institute, co-authoring numerous publications in esteemed journals. His focus on ocular surface tumors and brain injury has earned him recognition in the medical research community. David is passionate about scientific discovery and its real-world applications, aiming to bridge the gap between research and patient care. He is currently expanding his knowledge in traumatic brain injuries and their long-term outcomes through ongoing projects. His collaborative spirit and dedication to ethical research practices have positioned him as a promising young researcher in the medical field.

Professional Profile

  • orcid

    Education :

    David Monroy earned his Bachelor of Science in Biological Sciences from Florida International University (FIU) in 2020, where he followed a pre-medical track. As a student at FIU, David participated in various research programs, including the SEA-PHAGES program, where he discovered and analyzed novel bacteriophages. His educational journey was marked by an honors-level academic experience, which equipped him with the critical thinking and technical skills necessary for scientific research. Additionally, his time at FIU fostered a deep interest in neurobiology and medical sciences, which laid the groundwork for his subsequent research into neurocritical care and ophthalmology. Throughout his studies, David developed a comprehensive understanding of biological systems, disease mechanisms, and medical treatments, all while maintaining a high standard of academic achievement. His undergraduate experiences have significantly influenced his career trajectory in medical research.

    Experience :

    David Monroy’s research career includes notable roles such as Neurocritical Care Research Associate at the University of Miami, where he currently supports clinical studies in the neurosurgical intensive care unit. His work involves ensuring adherence to ethical protocols, communicating with patient families, and contributing to impactful studies on traumatic brain injury. Previously, David participated in ophthalmology research at the Bascom Palmer Eye Institute, focusing on ocular surface tumors and diagnostic techniques. He has authored multiple manuscripts and presented research findings at conferences, demonstrating his ability to communicate complex data effectively. During his time at Florida International University, he interned in a Parkinson’s disease research lab, where he gained experience in laboratory techniques and the study of neurodegenerative diseases. David’s career reflects a commitment to advancing medical knowledge through both clinical and basic science research, with a focus on improving patient care outcomes.

    Awards and Honors :

    David Monroy’s research and academic excellence have earned him several accolades. His work at the University of Miami’s Department of Neurology has been recognized for its contributions to understanding traumatic brain injuries, leading to multiple poster presentations at the prestigious Neurocritical Care Society conferences. Additionally, his studies on ocular surface tumors at the Bascom Palmer Eye Institute have resulted in peer-reviewed publications and presentations at the Association for Research in Vision and Ophthalmology (ARVO) conference. David’s commitment to advancing scientific knowledge has been rewarded with co-authorship on high-impact medical papers, underscoring his role in groundbreaking discoveries. While at Florida International University, he was part of the honors college, a testament to his academic dedication. His volunteer efforts, particularly with underserved communities, have also been recognized, reflecting his commitment to both research and service.

    Research Focus :

    David Monroy’s research is primarily focused on neurocritical care and ophthalmology, with an emphasis on traumatic brain injury and ocular surface tumors. In neurocritical care, his work has centered on understanding the cognitive and motor dissociation in brain injury patients, as well as examining the causes of traumatic brain injuries across different demographics. His research aims to improve long-term patient outcomes through innovative treatments and monitoring techniques. In ophthalmology, David has explored the infectious etiology of conjunctival tumors and developed diagnostic modalities for ocular surface squamous neoplasia. His research seeks to enhance early detection and improve therapeutic interventions for patients with ocular diseases. By collaborating with multidisciplinary teams, David continues to contribute to research that bridges the gap between laboratory findings and clinical applications, ensuring that his work has a tangible impact on patient care.

    Publication Top notes :

    • 📘 Alvarez OP., Monroy D., Thura S., et al. Infectious Etiology of Conjunctival Tumors. Expert Review of Ophthalmology, 2024.
    • 👁️ Monroy D., Venkateswaran N., Matthews JL., et al. Conjunctival keratoacanthoma: a clinical and histopathological case series. Canadian Journal of Ophthalmology, 2024.
    • 🔬 Monroy D., Serrano A., Galor A., & Karp CL. Medical treatments for ocular surface squamous neoplasia. Eye, 2023.
    • 💀 Monroy D., Garcia J., Zarate SD., et al. Displaced humeral pathological fracture secondary to intraosseous hemangioma. Radiology Case Reports, 2022.

Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl | Health Professions | Academic Excellence Award

Prof Dr Arnulf Stenzl, Universität Tübingen, Tübingen Deutschland ,Germany

Prof. Dr. Arnulf Stenzl is an Austrian-born urologist and global leader in urological oncology. He received his medical degree from Karl-Franzens University in Graz, Austria, in 1980 and subsequently trained in surgery and urology across Austria, Switzerland, and the United States. Since 2002, he has headed the Department of Urology at Eberhard-Karls University in Tübingen, Germany, where he oversees critical research on urological cancers. Prof. Stenzl’s contributions extend internationally, with membership in numerous editorial boards and global collaborations. He has played a pivotal role in shaping European urological policies as Secretary General of the European Association of Urology. His work has led to several groundbreaking patents in the field, furthering innovations in patient care.

Professional Profile

Education 

Prof. Dr. Arnulf Stenzl embarked on his academic journey in 1973 when he enrolled at Karl-Franzens University in Graz, Austria, where he earned his Doctor medicinae universalis (M.D.) in February 1980. His initial training spanned internal medicine, nephrology, and pathology at Landeskrankenhaus Klagenfurt and Karl-Franzens University. From 1984 to 1987, he undertook specialized training in urology, first at Karl-Franzens University, then further expanding his knowledge as a fellow in general urology and urologic oncology at the University of California, Los Angeles (UCLA). His education, which encompassed diverse fields such as trauma, vascular, and plastic surgery, provided him with a holistic understanding of medicine and surgery. His dedication to learning has been reflected in his ongoing research and innovative contributions to urology.

Experience 

Prof. Dr. Arnulf Stenzl has had a distinguished career spanning over three decades. After serving as an assistant professor at the University of Bern in Switzerland, he moved to the University of Innsbruck, Austria, where he eventually became vice-chairman of the Department of Urology. Since 2002, he has led the Department of Urology at Eberhard-Karls University Tübingen, Germany, overseeing the clinical, academic, and research arms of the institution. Prof. Stenzl has driven numerous groundbreaking research projects, collaborating with both academic and industrial partners. As Secretary General of the European Association of Urology, he has led European urological research and development initiatives. His expertise extends to cancer research, with numerous contributions to advancing treatment modalities for bladder and prostate cancer.

Awards and Honors 

Prof. Dr. Arnulf Stenzl’s career is marked by numerous prestigious awards and honors. He is an honorary member of several international urological societies, including the Bristol Urological Institute and the Canadian Urological Association. His service as President of the German Urological Association (2020-2021) highlights his leadership within the field. Additionally, his involvement as Chairman of the Scientific Congress Office for the European Association of Urology and his role on the Board of Directors of the European CanCer Organisation demonstrate his commitment to global urological advancement. Prof. Stenzl’s contributions to scientific literature have earned him multiple editorial board memberships. His innovative spirit is further evidenced by several patents, including implantable devices to treat urinary incontinence and risk prediction models for renal cell carcinoma.

Research Focus 

Prof. Dr. Arnulf Stenzl’s research is at the forefront of urological oncology, focusing on advanced treatment modalities for bladder and prostate cancers. His work delves into personalized cancer therapies, optimizing clinical outcomes through precision medicine approaches. A significant aspect of his research revolves around biomarker discovery and risk stratification, which aim to enhance early diagnosis and targeted treatment. He has contributed to pioneering studies in immunotherapy, including innovative techniques for bladder cancer surgery and the integration of novel hormonal therapies in prostate cancer treatment. Prof. Stenzl is also involved in collaborative research projects with industry, furthering the development of next-generation urological treatments. His innovative contributions have resulted in several patents, solidifying his standing as a leader in urological research and technology.


Publications top notes

  • Treatment Intensification With Novel Hormonal Therapy in Prostate Cancer 📚🧪
  • Sacituzumab Govitecan Efficacy in Urothelial Cancer 🧬🔬
  • Co-occurring BRCA2/SPOP Mutations and PARP Inhibitor Sensitivity 🧬⚕️
  • Epacadostat Plus Pembrolizumab for Urothelial Carcinoma 💉🧪
  • Impact of Teratoma on Survival in Germ Cell Cancer 🧫🩺
  • Sacituzumab Govitecan & Pembrolizumab in Urothelial Cancer 💊🧪
  • TROPHY-U-01 Study on Sacituzumab Govitecan in Metastatic Urothelial Cancer 🧬🔬
  • Efficacy of Darolutamide in Black Patients With Prostate Cancer ⚕️🩺
  • Alpha Emitter for Metastatic Castration-Resistant Prostate Cancer 🧬💉